Abstract
We established two glioma cell lines from two surgical specimens obtained at different times from the same patient. One (No. 9R), which was derived from the recurrent tumor (glioblastoma, grade IV), proliferated more rapidly in vitro than the other (No. 9) from the primary tumor (slightly anaplastic astrocytoma, grade II–III). No. 9R showed heterotransplantability in nude mice, whereas No. 9 did not. These findings indicate that No. 9R has a more aggressive or malignant nature than No. 9. Both cell lines showed homozygous deletion of the representative tumor suppressor p16 and p15 genes, but no p53 gene alteration. However, examination of the overall mRNA expression profile using a commercially available cDNA-spotted membrane revealed much higher expression levels of several mRNAs, at least, in No. 9R than in No. 9, although the relationship between these mRNAs and the growth potentials remained unknown. These two cell lines, derived from the same individual, with different proliferating potentials may be useful for studies on the molecular bases of glioma malignancy and progression.
Similar content being viewed by others
References
The Committee of Brain Tumor Registry of Japan: Special issue. Neurol Med Chir (Tokyo) 32: 391–417, 1992
Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P: Grading of astrocytomas.Asimple and reproducible method. Cancer 62: 2152–2165, 1988
Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System. Springer-Verlag, 1993, ed 2, pp 11–14
Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous System. London, Edward Arnold, 1977, ed 4, pp p146–244
Hayashi Y, Yamashita J, Yamaguchi K:Timing and role of p53 gene mutation in the recurrence of glioma. Biochem Biophys Res Commun 180: 1145–1150, 1991
Koga H, Zhang SJ, Kumanishi T, Washiyama K, Ichikawa T, Tanaka R, Mukawa J: Analysis of p53 gene mutations in low-and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry. Acta Neuropathol 87: 225–232, 1994
Louis DN, von Deimling A, Chung RY, Rubio M-P, Whaley JM, Eibl RH, Ohgaki H, Wiestler OD, Thor AD, Seizinger BR: Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 52: 31–38, 1992
Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K: Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6: 1313–1318, 1991
Zhang SJ, Feng XL, Koga H, Ichikawa T, Abe S, Kumanishi T: p53 gene mutations in pontine gliomas of juvenile onset. Biochem Biophys Res Commun 196: 851–857, 1993
Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, Vogelstein B: Deletion of p16 and p15 genes in brainumors. Cancer Res 54: 6353–6358, 1994
Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436–440, 1994
Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753–756, 1994
Schmidt EE, Ichimura K, Reifenberger G, Collins VP: CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54: 6321–6324, 1994
Onda K, Tanaka R, Washiyama K, Takeda N, Kumanishi T: Correlation of DNA ploidy and morphological features of human glioma cell cultures with the establishment of cell lines. Acta Neuropathol 76: 433–440, 1988
Harris M: Quantitative growth studies with chick myoblasts in glass substrate cultures. Growth 21: 149–166, 1957
Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766–2770, 1989
Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350: 427–428, 1991
Kumanishi T, Zhang SJ, Ichikawa T, Endo S, Washiyama K: Primary malignant lymphoma of the brain: demonstration of frequent p16 and p15 gene deletions. Jpn J Cancer Res 87: 691–695, 1996
Zhang SJ, Endo S, Koga H, Ichikawa T, Feng XL, Onda K, Washiyama K, Kumanishi T: A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations. Jpn J Cancer Res 87: 900–907, 1996
Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y: Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54: 3396–3397, 1994
Usui H, Ichikawa T, Miyazaki Y, Nagai S, Kumanishi T: Isolation of cDNA clones of the rat mRNAs expressed preferentially in the prenatal stages of brain development. Develop Brain Res 97: 185–193, 1996
Bigner DD, Bigner SH, Pont´en J, Westermark B, Mahaley MS, Ruoslahti E, Herschman H, Eng LF, Wikstrand CJ: Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. JNeuropathol Exp Neurol 40: 201–229, 1981
Maunoury R: Establishment and characterization of 5 human cell lines derived from a series of 50 primary intracranial tumors. Acta Neuropathol 39: 33–41, 1977
Pont´en J, Macintyre EH: Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 74: 465–486, 1968
Rutka JT, Giblin JR, Dougherty DY, Liu HC, McCulloch JR, Bell CW, Stern RS, Wilson CB, Rosenblum ML: Establishment and characterization of five cell lines derived from human malignant gliomas. Acta Neuropathol 75: 92–103, 1987 254
Studer A, de Tribolet N, Diserens AC, Gaide AC, Matthieu JM, Carrel S, Stavrou D: Characterization of four human malignant glioma cell lines. Acta Neuropathol 66: 208–217, 1985
Westermark B, Pont´en J, Hugosson R: Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol Microbiol Scand 81: 791–805, 1973
Allalunis-Turner MJ, Barron GM, Day III RS, Dobler KD, Mirzayans R: Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiat Res 134: 349–354, 1993
Eliyahu D, Michalovitz D, Oren M: Overproduction of p53 antigen makes established cells highly tumorigenic. Nature 316: 158–160, 1985
Venter DJ, Bevan KL, Ludwig RL, Riley TEW, Jat PS, Thomas DGT, Noble MD: Retinoblastoma gene deletions in human glioblastomas. Oncogene 6: 445–448, 1991
Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis G, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittman M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275: 1943–1947, 1997
Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Lignon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Swedlund B, Teng DHF, Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356–362, 1997
Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ulrich A, Schlessinger J: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature 313: 144–147, 1985
Mørk SJ, Laerum OD: DNA distribution in human gliomas in vivo and in vitro. In: Laerum OD, Lindmo T, Thorud E(eds) Flow Cytometry IV. Universitetsforlaget, Oslo, pp 403–406
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Onda, K., Nagai, S., Tanaka, R. et al. Establishment of Two Glioma Cell Lines from Two Surgical Specimens Obtained at Different Times from the Same Individual. J Neurooncol 41, 247–254 (1999). https://doi.org/10.1023/A:1006172608019
Issue Date:
DOI: https://doi.org/10.1023/A:1006172608019